In Silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  George Priya Doss, C ^a  

^a VIT UNIVERSITY   (India)

Author keywords

F8; F9; Haemophilia A; Haemophilia B; In silico

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DELETION MUTANT; F8 GENE; F9 GENE; GENE; GENE CONTROL; GENOME; GENOTYPE PHENOTYPE CORRELATION; HEMOPHILIA A; HEMOPHILIA B; HUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPORT VECTOR MACHINE;

EID: 84861563514     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-30     Document Type: Article

References (141)

1. Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females. Renault NK, Dyack S, Dobson MJ, Costa T, Lam WL, Greer WL, Eur J Hum Genet 2007 15 6 628 637 10.1038/sj.ejhg.5201799 17342157 (Pubitemid 46825052)
2. Haemophilia B: database of point mutations and short additions and deletions. Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG, Nucleic Acids Res 7 1998 26 1 265 268 10.1093/nar/26.1.265 9399849 (Pubitemid 28291540)
3. Haemophilia A and haemophilia B: molecular insights. Bowen DJ, Mol Pathol 2002 55 127 440 10.1136/mp.55.2.127 11950963 (Pubitemid 34293416)
4. Structure of human factor VIII. Vehar GA, Keyt B, Eaton D, Rodriguez H, O Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EGD, Lawn RM, Dapon DJ, Nature 1984 312 337 42 10.1038/312337a0 6438527 (Pubitemid 15209310)
5. Molecular basis of haemophilia A. Oldenburg J, Ananyeva NM, Saenko EL, Haemophilia 2004 10 4 133 139 10.1111/j.1365-2516.2004.01005.x 15479386 (Pubitemid 40045432)
6. Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data. Ivaskevicius V, Jurgutis R, Rost S, Müller A, Schmitt C, Wulff K, Herrmann FH, Muller CR, Schwaab R, Oldenburg J, Br J Haematol 2001 112 1062 70 10.1046/j.1365-2141.2001.02671.x 11298607 (Pubitemid 32322937)
7. Molecular biology of haemophilia B. Roberts HR, Thromb Haemost 1993 70 1 9 8236083
8. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Yoshitake S, Shach BG, Foster DC, Davie EW, Kurachi K, Biochemistry 1985 24 3736 3750 10.1021/bi00335a049 2994716 (Pubitemid 15011912)
9. HAMSTeRS Database. http://hadb.org.uk/
10. Definitions in Haemophlia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, On behalf of the Factor VIII and Factor IX Subcommittee, Thromb Haem 2001 85 560 (Pubitemid 32233035)
11. Human non-synonymous SNPs: server and survey. Ramensky V, Bork P, Sunyaev S, Nucleic Acids Res 2002 30 17 3894 3900 10.1093/nar/gkf493 12202775 (Pubitemid 35012462)
12. The human gene mutation database: 2008 update. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, Cooper DN, Genome Medicine 2009 1 13 10.1186/gm13 19348700
13. Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Botstein D, Risch N, Nat Genet 2003 33 228 237 10.1038/ng1090 12610532 (Pubitemid 36278833)
14. Amino acid difference formula to help explain protein evolution. Grantham R, Science 1974 185 862 864 10.1126/science.185.4154.862 4843792
15. SNAP: predict effect of non-synonymous polymorphisms on function. Bromberg Y, Rost B, Nucleic Acids Res 2007 35 3823 3835 10.1093/nar/gkm238 17526529 (Pubitemid 47244674)
16. SIFT: predicting amino acid changes that affect protein function. Ng PC, Henikoff S, Nucleic Acids Res 2003 31 3812 3814 10.1093/nar/gkg509 12824425 (Pubitemid 37442253)
17. SNPper: retrieval and analysis of human SNPs. Riva A, Kohane IS, Bioinformatics 2002 18 1681 1685 10.1093/bioinformatics/18.12.1681 12490454 (Pubitemid 36097734)
18. topoSNP: a topographic database of non-synonymous single nucleotide polymorphisms with and without known disease association. Stitziel NO, Binkowski TA, Tseng YY, Kasif S, Liang J, Nucleic Acids Res 2004 1 32 520 D522
19. CanPredict: a computational tool for predicting cancer-associated missense mutations. Joshua SK, Yan Z, Colin W, Zemin Z, Nucleic Acids Res 2007 35 595 W598 10.1093/nar/gkm405 17537827
20. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Kumar P, Henikoff S, Ng PC, Nat Protoc 2009 4 1073 1081 10.1038/nprot.2009.86 19561590
21. I-Mutant2. 0: predicting stability changes upon mutation from the protein sequence or structure. Capriotti E, Fariselli P, Casadio R, Nucleic Acids Res 2005 33 306 10.1093/nar/gki375 15980478 (Pubitemid 44529932)
22. UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Grillo G, Turi A, Licciulli F, Mignone F, Liuni S, Banfi S, Gennarino VA, Horner DS, Pavesi G, Picardi E, Pesole G, Nucleic Acids Res 2010 38 75 D80 10.1093/nar/gkp902 19880380
23. Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNPeffect and PupaSuite databases. Reumers J, Conde L, Medina I, Maurer-Stroh S, Van Durme J, Dopazo J, Rousseau F, Schymkowitz J, Nucleic Acids Res 2008 36 825 D829 18086700
24. Database resources of the National Center for Biotechnology Information. Eric WS, Tanya B, Dennis AB, Evan B, Stephen HB, Kathi C, Vyacheslav C, Deanna MC, Michael D, Scott F, Michael F, Ian MF, Lewis YG, Wolfgang H, Yuri K, David L, David JL, Zhiyong L, Thomas LM, Tom M, Donna RM, Aron MB, Vadim M, Ilene M, James O, Anna P, Lon P, Kim DP, Gregory DS, Edwin S, Stephen TS, Martin S, Karl S, Douglas S, Alexandre S, Grigory S, Tatiana AT, Lukas W, Yanli W, W JW, Eugene Y, Jian Y, Nucleic Acids Res 2011 39 38 D51 10.1093/nar/gkq1172 21097890
25. The SWISS-PROT Protein Sequence Data Bank and Its New Supplement TREMBL. Amos B, Rolf A, Nucleic Acids Res 1996 24 1 21 25 10.1093/nar/24.1.21 8594581 (Pubitemid 26085725)
26. McKusick's Online Mendelian Inheritance in Man (OMIM). Amberger J, Bocchini CA, Scott AF, Hamosh A, Nucleic Acids Res 2009 37 793 D796 10.1093/nar/gkn665 18842627
27. Predicting the functional consequences of nonsynonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. Chasman D, Adams RM, J Mol Biol 2001 307 683 706 10.1006/jmbi.2001.4510 11254390 (Pubitemid 33027685)
28. Prediction of deleterious human alleles. Sunyaev S, Ramensky V, Koch I, Lathe W, Kondrashov A, Bork P, Hum Mol Genet 2001 10 591 597 10.1093/hmg/10.6.591 11230178 (Pubitemid 32229363)
29. SNPs, protein structure, and disease. Wang Z, Moult J, Hum Mutat 2001 17 263 270 10.1002/humu.22 11295823 (Pubitemid 32268400)
30. Genome bioinformatic analysis of nonsynonymous SNPs. Burke DF, Worth CL, Priego E, Cheng T, Smink LJ, Todd JA, Blundell TL, BMC Bioinformatics 2007 8 301 315 10.1186/1471-2105-8-301 17708757
31. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Xi T, Jones IM, Mohrenweiser HW, Genomics 2005 83 970 979 (Pubitemid 38726046)
32. Predicting deleterious amino acid substitutions. Ng PC, Henikoff S, Genome Res 2001 11 863 874 10.1101/gr.176601 11337480 (Pubitemid 32447869)
33. PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping Purposes. Conde L, Vaquerizas JM, Ferrer-Costa C, Orozco M, Dopazo J, Nucleic Acids Res 2005 33 501 W505 10.1093/nar/gki476 15980522 (Pubitemid 44529971)
34. mRNA translation: influence of the 5' and 3' untranslated Regions. Sonenberg N, Curr Opin Genet 1994 4 2 310 15 10.1016/S0959-437X(05)80059-0
35. Mining treasures from 'junk DNA'. Nowak R, Science 1994 263 608 610 10.1126/science.7508142 7508142
36. The SAAPdb web resource: a large-scale structural analysis of mutant proteins. Hurst JM, McMillan LE, Porter CT, Allen J, Fakorede A, Martin AC, Hum Mutat 2009 30 4 616 624 10.1002/humu.20898 19191322
37. The tertiary structure and domain organization of coagulation factor VIII. Shen BW, Spiegel PC, Chang CH, Huh JW, Lee JS, Kim J, Kim YH, Stoddard BL, Blood 2008 111 3 1240 1247 17965321 (Pubitemid 351213406)
38. Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding. Hopfner KP, Lang A, Karcher A, Sichler K, Kopetzki E, Brandstetter H, Huber R, Bode W, Engh RA, Structure 1999 7 8 989 996 10.1016/S0969-2126(99)80125-7 10467148 (Pubitemid 29372520)
39. Swiss-PDB Viewer (Deep View). Kaplan W, Littlejohn TG, Brief Bioinform 2001 2 2 195 197 10.1093/bib/2.2.195 11465736
40. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. Hess B, Kutzner C, van der Spoel D, Lindahl E, J Chem Theory Comput 2008 4 435 447 10.1021/ct700301q
41. Biomolecular Simulation: The GROMOS96 Manual and User Guide. Van Gunsteren WF, Billeter SR, Eising AA, Hunenberger PH, Kruger P, Mark AE, Scott WRP, Tironi IG, vdf Hochschulverlag AG an der ETH Zurich and BIOMOS b.v: Zurich, Groningen 1996
42. Comparison of simple potential functions for simulating liquid water. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, J Chem Phys 1983 79 926 935 10.1063/1.445869
43. Bioinformatics and molecular modeling in chemical enzymology. Active sites of hydrolases. Varfolomeev SD, Uporov IV, Fedorov EV, Biochemistry 2002 67 10 1099 1108 10.1023/A:1020907122341 12460108 (Pubitemid 35468951)
44. A method to identify protein sequences that fold into a known three-dimensional structure. Bowie JU, Luthy R, Eisenberg D, Science 1991 253 164 170 10.1126/science.1853201 1853201 (Pubitemid 21917131)
45. Assessment of protein models with three dimensional profiles. Luthy R, Bowie JU, Eisenberg D, Nature 1992 356 83 85 10.1038/356083a0 1538787
46. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Wiederstein M, Sippl MJ, Nucleic Acids Res 2007 35 407 W410 10.1093/nar/gkm290 17517781
47. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. Fraczkiewicz R, Braun W, J Comp Chem 1998 19 319 333 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3. 0.CO;2-W (Pubitemid 128592649)
48. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Kabsch W, Sander C, Biopolymers 1998 22 2577 2637
49. Path to facilitate the prediction of functional amino acid substitutions in red blood cell disorders-a computational approach. Rajith B, George Priya Doss C, PLoS ONE 2011 6 9 24607 10.1371/journal.pone.0024607 21931771
50. Screen of 55 Slovenian haemophilia A patients: identification of 2 novel mutations (S-1R and IVS23+1G- > A) and discussion of mutation spectrum. Mutation in brief no. 241. Online. Strmecki L, Benedik-Dolnicar M, Vouk K, Komel R, Hum Mutat 1999 13 5 413 10338101
51. The identification and classification of 41 novel mutations in the factor VIII gene (F8C). Cutler JA, Mitchell MJ, Smith MP, Savidge GF, Hum Mutat 2002 19 274 278 10.1002/humu.10056 11857744 (Pubitemid 34195189)
52. Start of UK confidential haemophilia A database: analysis of 142 patients by solid phase fluorescent chemical cleavage of mismatch. Haemophilia Centres. Waseem NH, Bagnall R, Green PM, Giannelli F, Thromb Haemost 1999 81 6 900 905 10404764 (Pubitemid 29312704)
53. Characterization of the factor VIII defect in 147 patients with sporadic Haemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Becker J, Schwaab R, Moeller-Taube A, Schwaab U, Schmidt W, Brackmann HH, Grimm T, Olek K, Oldenburg J, Am J Hum Genet 1996 58 657 670 8644728
54. Amino acid substitutions in conserved domains of factor VIII and related proteins: study of patients with mild and moderately severe haemophlia A. Diamond C, Kogan S, Levinson B, Gitschier J, Hum Mutat 1992 1 248 257 10.1002/humu.1380010312 1301932
55. Mutational analysis of ectopic factor VIII transcripts from haemophlia A patients: identification of cryptic splice site, exon skipping and novel point mutations. Tavassoli K, Eigel A, Pollmann H, Horst J, Hum Genet 1997 100 5-6 508 511 10.1007/s004390050543 9341862 (Pubitemid 28072346)
56. Skewed X-chromosome inactivation in monochorionic diamniotic twin sisters results in severe and mild haemophlia A. Valleix S, Vinciguerra C, Lavergne J-M, Leuer M, Delpech M, Negrier C, Blood 2002 100 3034 3036 10.1182/blood-2002-01-0277 12351418
57. Non-inversion factor VIII mutations in 80 haemophlia A families including 24 with alloimmune responses. Liu ML, Nakaya S, Thompson AR, Thromb Haemost 2002 87 2 273 276 11858487 (Pubitemid 34139864)
58. Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations. Timur AA, Guergey A, Aktuglu G, Kavakli K, Canatan D, Olek K, Caglayan SH, Haemophilia 2001 7 475 481 10.1046/j.1365-2516.2001. 00548.x 11554935 (Pubitemid 32923252)
59. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group. Goodeve AC, Williams I, Bray GL, Peake IR, Thromb Haemost 2000 83 6 844 848 10896236 (Pubitemid 30411681)
60. Analysis of 18 novel mutations in the factor VIII gene. Bicocchi MP, Pasino M, Lanza T, Bottini F, Boeri E, Mori PG, Molinari AC, Rosano C, Acquila M, Br J Haematol 2003 122 810 817 10.1046/j.1365-2141.2003.04494.x 12930394 (Pubitemid 37100309)
61. Detection of mutations in ectopic factor VIII transcripts from nine haemophilia A patients and the correlation with phenotype. Bidichandani SI, Lanyon WG, Shiach CR, Lowe GD, Connor JM, Hum Genet 1995 95 5 531 538 7759074
62. Identification of 31 novel mutations in the F8 gene in Spanish haemophlia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites. Vencesla A, Corral-Rodriguez MA, Baena M, Cornet M, Domenech M, Baiget M, Fuentes-Prior P, Tizzano EF, Blood 2008 111 3468 3478 10.1182/blood-2007-08-108068 18184865
63. Mild haemophilia A discovered in a previously multi-operated 73-year-old man: characterization of a new mutation. Bauduer F, Ducout L, Bendriss P, Falaises B, Lavergne JM, Haemophilia 2001 7 4 419 421 11442647 (Pubitemid 32677663)
64. A domain mutations in 65 haemophilia A families and molecular modelling of dysfunctional factor VIII proteins. Liu M, Murphy MEP, Thompson AR, Br J Haematol 1998 103 1051 1060 10.1046/j.1365-2141.1998.01122.x 9886318 (Pubitemid 29012642)
65. Molecular characterization of severe Haemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Higuchi M, Kazazian HH Jr, Kasch L, Warren TC, McGinniss MJ, Phillips JA, Kasper C, Janco R, Antonarakis SE, Proc Natl Acad Sci 1991 88 7405 7409 10.1073/pnas.88.16.7405 1908096 (Pubitemid 21915160)
66. Small FVIII gene rearrangements in 18 haemophlia A patients: five novel mutations. Bicocchi MP, Pasino M, Lanza T, Bottini F, Molinari AC, Caprino D, Rosano C, Acquila M, Am J Hematol 2005 78 2 117 122 10.1002/ajh.20234 15682412 (Pubitemid 40194103)
67. Eleven novel mutations in the factor VIII gene from Brazilian haemophlia A patients. Arruda VR, Pieneman WC, Reitsma PH, Deutz-Terlouw PP, Annichino-Bizzacchi JM, Brieet E, Costa FF, Blood 1995 86 3015 3020 7579394
68. Protein truncation test: detection of severe haemophilia a mutation and analysis of factor VIII transcripts. Maugard C, Tuffery S, Aguilar-Martinez P, Schved JF, Gris JC, Demaille J, Claustres M, Hum Mutat 1998 11 1 18 22 9450898 (Pubitemid 128679144)
69. Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A. Theophilus BDM, Enayat MS, Williams MD, Hill FGH, Haemophilia 2001 7 381 391 10.1046/j.1365-2516.2001.00528.x 11442643 (Pubitemid 32677657)
70. Somatic mosaicism in Haemophilia A: a fairly common event. Leuer M, Oldenburg J, Lavergne JM, Ludwig M, Fregin A, Eigel A, Ljung R, Goodeve A, Peake I, Olek K, Am J Hum Genet 2001 69 75 87 10.1086/321285 11410838 (Pubitemid 32614020)
71. 11 haemophlia A patients without mutations in the factor VIII encoding gene. Klopp N, Oldenburg J, Uen C, Schneppenheim R, Graw J, Thromb Haemost 2002 88 2 357 360 12195713 (Pubitemid 34873722)
72. Molecular characterization of haemophilia A in southern Chinese. Chan V, Pang A, Chan TPT, Chan VW-Y, Chan TK, Br J Haematol 1996 93 451 456 10.1046/j.1365-2141.1996.4981042.x 8639447 (Pubitemid 26148749)
73. Identification of factor VIII gene mutations in patients with severe haemophilia A in Venezuela: identification of seven novel mutations. Albanez S, Ruiz-Saez A, Boadas A, De Bosch N, Porco A, Haemophilia 2011 17 913 918
74. Rapid haemophlia A molecular diagnosis by a simple DNA sequencing procedure: identification of 14 novel mutations. Vidal F, Farssac E, Altisent C, Puig L, Gallardo D, Thromb Haemost 2001 85 4 580 583 11341489 (Pubitemid 32293690)
75. Factor VIII deficiency not induced by FVIII gene mutation in a female first cousin of two brothers with haemophilia A. Mazurier C, Parquet-Gernez A, Gaucher C, Lavergne J-M, Goudemand J, Br J Haematol 2002 119 390 392 10.1046/j.1365-2141.2002.03819.x 12406074 (Pubitemid 35365487)
76. Mutational-screening in the factor VIII gene resulting in the identification of three novel mutations, one of which is a donor splice mutation. Mutations in brief no. 245. Online. Möller-Morlang K, Tavassoli K, Eigel A, Pollmann H, Horst J, Hum Mutat 1999 13 6 504 10408785
77. Screening for mutations in haemophilia A patients by multiplex PCR-SSCP, Southern blotting and RNA analysis: the detection of a genetic abnormality in the factor VIII gene in 30 out of 35 patients. Pieneman WC, Deutz-Terlouw PP, Reitsma PH, Brieet E, Br J Haematol 1995 90 442 449 7794769
78. Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. Williams IJ, Abuzenadah A, Winship PR, Preston FE, Dolan G, Wright J, Peake IR, Goodeve AC, Thromb Haemost 1998 79 4 723 726 9569180 (Pubitemid 28163842)
79. Genotype and phenotype of haemophilia A in Thai patients. Yenchitsomanus P, Akkarapatumwong V, Pung-Amritt P, Intorasoot S, Thanootarakul P, Oranwiroon S, Veerakul G, Mahasandana C, Haemophilia 2003 9 179 186 10.1046/j.1365-2516. 2003.00729.x 12614369 (Pubitemid 36511654)
80. Fluorescent chemical cleavage of mismatches for efficient screening of the factor VIII gene. Freson K, Peerlinck K, Aguirre T, Arnout J, Vermylen J, Cassiman JJ, Matthijs G, Hum Mutat 1998 11 6 470 479 10.1002/(SICI)1098- 1004(1998)11:6<470::AID-HUMU8>3.0.CO;2-A 9603440 (Pubitemid 28196721)
81. Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism. Morichika S, Shima M, Kamisue S, Tanaka I, Imanaka Y, Suzuki H, Shibata H, Pemberton S, Gale K, McVey J, Tuddenham EGD, Yoshioka A, Br J Haematol 1997 98 901 906 10.1046/j.1365-2141.1997.2963113.x 9326186 (Pubitemid 27421632)
82. Moderately severe haemophlia A resulting from Glu- > Gly substitution in exon 7 of the factor VIII gene. Youssoufian H, Wong C, Aronis S, Platokoukis H, Kazazian HH Jr, Antonarakis SE, Am J Hum Genet 1988 42 867 871 2835904
83. Experience of a single Italian center in genetic counseling for haemophlia: from linkage analysis to molecular diagnosis. Tagariello G, Belvini D, Salviato R, Are A, De Biasi E, Goodeve A, Davoli P, Haematologica 2000 85 525 529 10800171 (Pubitemid 30428577)
84. Mutations in the FVIII gene in seven families with mild haemophilia A. Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A, Br J Haematol 1997 96 2 426 427 10.1046/j.1365-2141.1997.d01-2008.x 9029040 (Pubitemid 27077387)
85. Thirty-four novel mutations detected in factor VIII gene by multiplex CSGE: modeling of 13 novel amino acid substitutions. Habart D, Kalabova D, Novotny M, Vorlova Z, J Thromb Haemost 2003 1 773 781 10.1046/j.1538-7836.2003. 00149.x 12871415
86. Seven novel and four recurrent point mutations in the factor VIII (F8C) gene. Bogdanova N, Lemcke B, Markoff A, Pollmann H, Dworniczak B, Eigel A, Horst J, Hum Mutat 2001 18 546 546 11748851
87. High throughput mutation screening of the factor VIII gene (F8C) in haemophlia A: 37 novel mutations and genotype-phenotype correlation. Citron M, Godmilow L, Ganguly T, Ganguly A, Hum Mutat 2002 20 267 274 10.1002/humu.10119 12325022
88. Mutations and a polymorphism in the factor VIII gene discovered by denaturing gradient gel electrophoresis. Kogan S, Gitschier J, Pro Natl Acad Sci 1990 87 2092 2096 10.1073/pnas.87.6.2092
89. Identification of seven novel mutations of F8C by DHPLC. Frusconi S, Passerini I, Girolami F, Masieri M, Linari S, Longo G, Morfini M, Torricelli F, Hum Mutat 2002 20 3 231 232 12203999
90. Identification of four novel mutations in the factor VIII gene: three missense mutations (E1875G, G2088S, I2185T) and a 2-bp deletion (1780delTC). Tavassoli K, Eigel A, Dworniczak B, Valtseva E, Horst J, Hum Mutat 1998 1 260 S262 9452104
91. Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype. Hill M, Deam S, Gordon B, Dolan G, Haemophilia 2005 11 133 141 10.1111/j.1365-2516.2005. 01069.x 15810915 (Pubitemid 40468061)
92. Intracellular accumulation of factor VIII induced by missense mutations Arg593- > Cys and Asn618- > Ser explains cross-reacting material-reduced haemophilia A. Roelse JC, De Laaf RT, Timmermans SM, Peters M, Van Mourik JA, Voorberg J, Br J Haematol 2000 108 2 241 246 10.1046/j.1365-2141.2000.01834.x 10691849 (Pubitemid 30143635)
93. Factor VIII inhibitors in mild and moderate-severity haemophilia A. Hay CRM, Ludlam CA, Colvin BT, Hill FGH, Preston FE, Wasseem N, Bagnall R, Peake IR, Berntorp E, Mauser Bunschoten EP, Fijnvandraat K, Kasper CK, White G, Santagostino E, Thromb Haemost 1998 79 762 766 9569189 (Pubitemid 28163851)
94. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Rudzki Z, Duncan EM, Casey GJ, Neumann M, Favaloro EJ, Lloyd JV, Br J Haematol 1996 94 400 406 10.1046/j.1365-2141.1996.d01-1792.x 8759905 (Pubitemid 26248003)
95. Spectrum of mutations in CRM-positive and CRM-reduced haemophlia A. McGinniss MJ, Kazazian HH Jr, Hoyer LW, Bi L, Inaba H, Antonarakis SE, Genomics 1993 15 2 392 8 10.1006/geno.1993.1073 8449505 (Pubitemid 23099807)
96. Identification of mutations in two families with sporadic haemophlia A. Paynton C, Sarkar G, Sommer SS, Hum Genet 1991 87 397 400 1908817
97. Detection of mutations in the factor VIII gene using single-stranded conformational polymorphism (SSCP). Economou EP, Kazazian HH Jr, Antonarakis SE, Genomics 1992 13 909 911 10.1016/0888-7543(92)90189-Y 1639429
98. A novel mutation (Arg- > Leu in exon 18) in factor VIII gene responsible for moderate Haemophilia A. Nafa K, Baudis M, Deburgrave N, Bardin JM, Sultan Y, Kaplan JC, Delpech M, Hum Mutat 1992 1 77 78 10.1002/humu. 1380010114 1301194
99. Female haemophlia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII. Cai XH, Wang XF, Dai J, Fang Y, Ding QL, Xie F, Wang HL, J Thromb Haemost 2006 4 9 1969 1974 10.1111/j.1538-7836.2006.02105.x 16805874 (Pubitemid 44226776)
100. Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1,5-angstrom human C2-domain crystal structure. Liu ML, Shen BW, Nakaya S, Pratt KP, Fujikawa K, Davie EW, Stoddard BL, Thompson AR, Blood 2000 96 979 987 10910913 (Pubitemid 30616863)
101. A novel cause of mild/moderate haemophlia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor. Jacquemin M, Lavend'homme R, Benhida A, Vanzieleghem B, D'Oiron R, Lavergne J-M, Brackmann HH, Schwaab R, VandenDriessche T, Chuah MKL, Hoylaerts M, Gilles JGG, Peerlinck K, Vermylen J, Saint-Remy J-MR, Blood 2000 96 958 965 10910910 (Pubitemid 30616860)
102. A novel missense mutation in the factor VIII gene identified by analysis of amplified haemophlia DNA sequences. Levinson B, Janco RL, Phillips JA III, Gitschier J, Nucleic Acids Re 1987 15 9797 9805 10.1093/nar/15.23.9797
103. Missense mutations causing mild haemophlia A in Iceland detected by denaturing gradient gel electrophoresis. Jonsdottir S, Diamond C, Levinson B, Magnusson S, Jensson O, Gitschier J, Hum Mutat 1992 1 6 506 508 10.1002/humu.1380010610 1301960
104. Three novel point mutations causing haemophilia A. Sukarova-Stefanovska E, Zisovski N, Muratovska O, Kostova S, Efremov GD, Haemophilia 2002 8 715 718 10.1046/j.1365-2516.2002.00661.x 12199686
105. Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG. Koeberl DD, Bottema CD, Buerstedde JM, Sommer SS, Am J Hum Genet 1989 45 3 448 457 2773937 (Pubitemid 19231326)
106. Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations. Onay UV, Kavakli K, Kilinç Y, Gürgey A, Aktulu G, Kemahli S, Ozbek U, Calayan SH, Br J Haematol 2003 120 4 656 659 10.1046/j.1365-2141.2003.04141.x 12588353 (Pubitemid 36255867)
107. A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel. Chu K, Wu SM, Stanley T, Stafford DW, High KA, J Clin Invest 1996 98 7 1619 1625 10.1172/JCI118956 8833911 (Pubitemid 26327872)
108. Germline mutations in Peruvian patients with haemophlia B: pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern. Heit JA, Thorland EC, Ketterling RP, Lind TJ, Daniels TM, Zapata RE, Ordonez SM, Kasper CK, Sommer SS, Hum Mutat 1998 11 5 372 376 10.1002/(SICI)1098-1004(1998) 11:5<372::AID-HUMU4>3.0.CO;2-M 9600455 (Pubitemid 28196637)
109. Three point mutations in the factor IX genes of five haemophlia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins. Chen SH, Thompson AR, Zhang M, Scott CR, J Clin Invest 1989 84 1 113 118 10.1172/JCI114130 2472424
110. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe haemophlia B. Wang NS, Zhang M, Thompson AR, Chen SH, Thromb Haemost 1990 63 1 24 26 2339358 (Pubitemid 20057307)
111. Molecular analyses in haemophlia B families: identification of six new mutations in the factor IX gene. Espinás C, Casãa P, Haya S, Cid AR, Aznar JA, Haematologica 2003 88 2 235 236 12604421 (Pubitemid 37101509)
112. Factor IXAlabama: a point mutation in a clotting protein results in haemophlia B. Davis LM, McGraw RA, Ware JL, Roberts HR, Stafford DW, Blood 1987 69 1 140 143 3790720 (Pubitemid 17007088)
113. Mutations associated with haemophlia B in Turkish patients. Caglayan SH, Gökmen Y, Aktuglu G, Gurgey A, Sommer SS, Hum Mutat 1997 10 1 76 79 10.1002/(SICI)1098-1004(1997)10:1<76::AID-HUMU11>3.0.CO;2-X 9222764 (Pubitemid 27298953)
114. Five novel factor IX mutations in unrelated haemophlia B patients. David D, Moreira I, Morais S, de Deus G, Hum Mutat 1998 1 301 S303 9452115
115. Factor IX gene sequencing by a simple and sensitive 15-hour procedure for haemophilia B diagnosis: identification of two novel mutations. Vidal F, Farssac E, Altisent C, Puig L, Gallardo D, Br J Haematol 2000 111 2 549 551 10.1046/j.1365-2141.2000.02389.x 11122099 (Pubitemid 32009349)
116. Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145. Noyes CM, Griffith MJ, Roberts HR, Lundblad RL, Proc Natl Acad Sci 1983 80 14 4200 4202 10.1073/pnas.80.14.4200 6603618 (Pubitemid 13077804)
117. Factor IX gene mutations causing haemophilia B: comparison of SSC screening versus systematic DNA sequencing and diagnostic applications. Aguilar-Martinez P, Romey MC, Schved JF, Gris JC, Demaille J, Claustres M, Hum Genet 1994 94 3 287 290 8076946 (Pubitemid 24262208)
118. Factor IX Cardiff: a variant factor IX protein that shows abnormal activation is caused by an arginine to cysteine substitution at position 145. Liddell MB, Peake IR, Taylor SA, Lillicrap DP, Giddings JC, Bloom AL, Br J Haematol 1989 72 4 556 560 10.1111/j.1365-2141.1989.tb04323.x 2775660 (Pubitemid 19220497)
119. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES, Nat Genet 1999 22 3 231 238 10.1038/10290 10391209 (Pubitemid 29297248)
120. Mutations in haemophlia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX. Bertina RM, van der Linden IK, Mannucci PM, Reinalda-Poot HH, Cupers R, Poort SR, Reitsma PH, J Biol Chem 1990 265 19 10876 10883 2162822
121. Blood clotting factor IX Kashihara: amino acid substitution of valine-182 by phenylalanine. Sakai T, Yoshioka A, Yamamoto K, Niinomi K, Fujimura Y, Fukui H, Miyata T, Iwanaga S, J Biochem 1989 105 5 756 759 2753873 (Pubitemid 19134451)
122. A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm. Taylor SA, Liddell MB, Peake IR, Bloom AL, Lillicrap DP, Br J Haematol 1990 75 2 217 221 10.1111/j.1365-2141.1990. tb02652.x 2372509
123. Single-strand conformation polymorphism (SSCP) analysis of the molecular pathology of haemophlia B. David D, Rosa HA, Pemberton S, Diniz MJ, Campos M, Lavinha J, Hum Mutat 1993 2 5 355 361 10.1002/humu.1380020506 8257988 (Pubitemid 23302194)
124. Haemophlia B caused by five different nondeletion mutations in the protease domain of factor IX. Ludwig M, Sabharwal AK, Brackmann HH, Olek K, Smith KJ, Birktoft JJ, Bajaj SP, Blood 1992 79 5 1225 1232 1346975
125. Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities. Miyata T, Sakai T, Sugimoto M, Naka H, Yamamoto K, Yoshioka A, Fukui H, Mitsui K, Kamiya K, Umeyama H, Iwanaga S, Biochemistry 1991 30 47 11286 11291 10.1021/bi00111a014 1958666
126. X-linked thrombophilia with a mutant factor IX (factor IX Padua). Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR, N Engl J Med 2009 361 17 1671 1675 10.1056/NEJMoa0904377 19846852
127. Haemophlia B in a female carrier due to skewed inactivation of the normal X-chromosome. Chan V, Chan VW, Yip B, Chim CS, Chan TK, Am J Hematol 1998 58 1 72 76 10.1002/(SICI)1096-8652(199805)58:1<72::AID-AJH13>3.0.CO;2-7 9590153 (Pubitemid 28213563)
128. Blood clotting factor IX Niigata: substitution of alanine-390 by valine in the catalytic domain. Sugimoto M, Miyata T, Kawabata S, Yoshioka A, Fukui H, Takahashi H, Iwanaga S, J Biochem 1988 104 6 878 880 3243764 (Pubitemid 19017425)
129. Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Attree O, Vidaud D, Vidaud M, Amselem S, Lavergne JM, Goossens M, Genomics 1989 4 3 266 272 10.1016/0888-7543(89)90330-3 2714791
130. Genetic defect responsible for the dysfunctional protein: factor IXLong Beach. Ware J, Davis L, Frazier D, Bajaj SP, Stafford DW, Blood 1988 72 2 820 822 3401602
131. The PyMOL Molecular Graphics System, Version 0.99. DeLano WL, DeLano Scientific San Carlos CA 2002
132. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function. Markoff A, Gerke V, Bogdanova N, Haemophlia 2009 15 4 932 941 10.1111/j.1365-2516.2009.02009.x
133. Detection and characterisation of two missense mutations at a cleavage site in the factor VIII light chain. Schwaab R, Ludwig M, Kochhan L, Oldenburg J, McVey JH, Egli H, Brackmann HH, Olek K, Thromb Res 1991 61 3 225 234 10.1016/0049-3848(91)90098-H 1851341
134. Three distinct point mutations in the factor IX gene of three Japanese CRM + haemophlia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4). Hamaguchi M, Matsushita T, Tanimoto M, Takahashi I, Yamamoto K, Sugiura I, Takamatsu J, Ogata K, Kamiya T, Saito H, Thromb Haemost 1991 65 5 514 520 1871712
135. Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNA. Higuchi M, Wong C, Kochhan L, Olek K, Aronis S, Kasper CK, Kazazian HH Jr, Antonarakis SE, Genomics 1990 6 1 65 71
136. Mapping of monoclonal antibodies to human factor IX. Frazier D, Smith KJ, Cheung WF, Ware J, Lin SW, Thompson AR, Reisner H, Bajaj SP, Stafford DW, Blood 1989 74 3 971 977 2473813 (Pubitemid 19210012)
137. Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select haemophlia B mutants. Bajaj SP, Thromb Haemost 1999 82 2 218 225 10605707
138. CoagMDB: a database analysis of missense mutations within four conserved domains in five vitamin K-dependent coagulation serine proteases using a text-mining tool. Saunders RE, Perkins SJ, Hum Mutat 2008 29 3 333 344 10.1002/humu.20629 18058827 (Pubitemid 351364934)
139. Structure-function roles of four cysteine residues in the human arsenic (+3 oxidation state) methyltransferase (hAS3MT) by site-directed mutagenesis. Song X, Geng Z, Zhu J, Li C, Hu X, Bian N, Zhang X, Wang Z, Chem Biol Interact 2009 179 2-3 321 328 10.1016/j.cbi.2008.12.018 19167370
140. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, et al. Nature 1992 358 646 653 10.1038/358646a0 1379696
141. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Savas S, Kim DY, Ahmad MF, Shariff M, Ozcelik H, Cancer Epidemiol Biomarkers Prev 2004 13 801 807 15159313 (Pubitemid 38737870)